These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 26531827)
1. Requirement for human Mps1/TTK in oxidative DNA damage repair and cell survival through MDM2 phosphorylation. Yu ZC; Huang YF; Shieh SY Nucleic Acids Res; 2016 Feb; 44(3):1133-50. PubMed ID: 26531827 [TBL] [Abstract][Full Text] [Related]
2. The cell cycle checkpoint kinase CHK2 mediates DNA damage-induced stabilization of TTK/hMps1. Yeh YH; Huang YF; Lin TY; Shieh SY Oncogene; 2009 Mar; 28(10):1366-78. PubMed ID: 19151762 [TBL] [Abstract][Full Text] [Related]
3. TTK/hMps1 participates in the regulation of DNA damage checkpoint response by phosphorylating CHK2 on threonine 68. Wei JH; Chou YF; Ou YH; Yeh YH; Tyan SW; Sun TP; Shen CY; Shieh SY J Biol Chem; 2005 Mar; 280(9):7748-57. PubMed ID: 15618221 [TBL] [Abstract][Full Text] [Related]
5. DNA damage-induced activation of ATM promotes β-TRCP-mediated Mdm2 ubiquitination and destruction. Wang Z; Inuzuka H; Zhong J; Fukushima H; Wan L; Liu P; Wei W Oncotarget; 2012 Sep; 3(9):1026-35. PubMed ID: 22976441 [TBL] [Abstract][Full Text] [Related]
6. ATM augments nuclear stabilization of DYRK2 by inhibiting MDM2 in the apoptotic response to DNA damage. Taira N; Yamamoto H; Yamaguchi T; Miki Y; Yoshida K J Biol Chem; 2010 Feb; 285(7):4909-19. PubMed ID: 19965871 [TBL] [Abstract][Full Text] [Related]
7. Interaction between RNF8 and DYRK2 is required for the recruitment of DNA repair molecules to DNA double-strand breaks. Yamamoto T; Taira Nihira N; Yogosawa S; Aoki K; Takeda H; Sawasaki T; Yoshida K FEBS Lett; 2017 Mar; 591(6):842-853. PubMed ID: 28194753 [TBL] [Abstract][Full Text] [Related]
8. TTK/hMps1 mediates the p53-dependent postmitotic checkpoint by phosphorylating p53 at Thr18. Huang YF; Chang MD; Shieh SY Mol Cell Biol; 2009 Jun; 29(11):2935-44. PubMed ID: 19332559 [TBL] [Abstract][Full Text] [Related]
9. DNA damage-induced expression of p53 suppresses mitotic checkpoint kinase hMps1: the lack of this suppression in p53MUT cells contributes to apoptosis. Bhonde MR; Hanski ML; Budczies J; Cao M; Gillissen B; Moorthy D; Simonetta F; Scherübl H; Truss M; Hagemeier C; Mewes HW; Daniel PT; Zeitz M; Hanski C J Biol Chem; 2006 Mar; 281(13):8675-85. PubMed ID: 16446370 [TBL] [Abstract][Full Text] [Related]
10. ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage. Chen L; Gilkes DM; Pan Y; Lane WS; Chen J EMBO J; 2005 Oct; 24(19):3411-22. PubMed ID: 16163388 [TBL] [Abstract][Full Text] [Related]
11. Human MPS1 kinase is required for mitotic arrest induced by the loss of CENP-E from kinetochores. Liu ST; Chan GK; Hittle JC; Fujii G; Lees E; Yen TJ Mol Biol Cell; 2003 Apr; 14(4):1638-51. PubMed ID: 12686615 [TBL] [Abstract][Full Text] [Related]
13. Quantitative mass spectrometry analysis reveals similar substrate consensus motif for human Mps1 kinase and Plk1. Dou Z; von Schubert C; Körner R; Santamaria A; Elowe S; Nigg EA PLoS One; 2011 Apr; 6(4):e18793. PubMed ID: 21533207 [TBL] [Abstract][Full Text] [Related]
14. A conserved RAD6-MDM2 ubiquitin ligase machinery targets histone chaperone ASF1A in tumorigenesis. Wang C; Chang JF; Yan H; Wang DL; Liu Y; Jing Y; Zhang M; Men YL; Lu D; Yang XM; Chen S; Sun FL Oncotarget; 2015 Oct; 6(30):29599-613. PubMed ID: 26336826 [TBL] [Abstract][Full Text] [Related]
15. Coordinated action of the Fanconi anemia and ataxia telangiectasia pathways in response to oxidative damage. Castillo P; Bogliolo M; Surralles J DNA Repair (Amst); 2011 May; 10(5):518-25. PubMed ID: 21466974 [TBL] [Abstract][Full Text] [Related]
16. TTK inhibitor promotes radiosensitivity of liver cancer cells through p21. Zhang H; Yao W; Zhang M; Lu Y; Tang J; Jiang M; Mou X; You G; Liang X Biochem Biophys Res Commun; 2021 Apr; 550():84-91. PubMed ID: 33689884 [TBL] [Abstract][Full Text] [Related]
17. Human Mps1 protein kinase is required for centrosome duplication and normal mitotic progression. Fisk HA; Mattison CP; Winey M Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14875-80. PubMed ID: 14657364 [TBL] [Abstract][Full Text] [Related]
18. Mitotic Checkpoint Kinase Mps1 Has a Role in Normal Physiology which Impacts Clinical Utility. Martinez R; Blasina A; Hallin JF; Hu W; Rymer I; Fan J; Hoffman RL; Murphy S; Marx M; Yanochko G; Trajkovic D; Dinh D; Timofeevski S; Zhu Z; Sun P; Lappin PB; Murray BW PLoS One; 2015; 10(9):e0138616. PubMed ID: 26398286 [TBL] [Abstract][Full Text] [Related]
19. TTK/hMPS1 is an attractive therapeutic target for triple-negative breast cancer. Maire V; Baldeyron C; Richardson M; Tesson B; Vincent-Salomon A; Gravier E; Marty-Prouvost B; De Koning L; Rigaill G; Dumont A; Gentien D; Barillot E; Roman-Roman S; Depil S; Cruzalegui F; Pierré A; Tucker GC; Dubois T PLoS One; 2013; 8(5):e63712. PubMed ID: 23700430 [TBL] [Abstract][Full Text] [Related]
20. Differing effects of breast cancer 1, early onset (BRCA1) and ataxia-telangiectasia mutated (ATM) mutations on cellular responses to ionizing radiation. Mamon HJ; Dahlberg W; Azzam EI; Nagasawa H; Muto MG; Little JB Int J Radiat Biol; 2003 Oct; 79(10):817-29. PubMed ID: 14630541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]